Gian Marco Ghiggeri

Nephrology — Istituto Giannina Gaslini, Italy

LeadR Profile

Gian Marco Ghiggeri Istituto Giannina Gaslini Italy
1 832 ScienceLeadR Reputation 1832
Network Map

Nephrology

Subspecialties: Immunology - Transplantation - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

Istituto Giannina Gaslini

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 531

Citations

Citations: 21 228 1st author: 46 Last author: 174 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Editorial: Case reports in autoimmune and autoinflammatory disorders, volume II.
vasculitis, immunotherapy, autoimmunity
Front Immunol20260
Extending the concept of 'exhausted T-cells' to idiopathic nephrotic syndrome.
kidney diseases, cells, nephrotic syndrome
Pediatr Nephrol20260
Kidney Survival in Children With Steroid-Resistant Nephrotic Syndrome Treated by Rituximab.
calcineurin, kidney, rituximab, nephrotic syndrome, steroids, child
Kidney Int Rep20260
The landscape of serum autoantibodies in lupus nephritis.
proteinuria, autoantibodies, serum, antibodies, lupus nephritis, biomarkers, signs and symptoms, histones, nephritis, autoimmunity
Autoimmun Rev20260
Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.
safety, nephrosis, lipoid, neutropenia, aged, rituximab, nephrotic syndrome, therapeutics, infections, child
Kidney Int Rep20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

Phase 2 5
N/A 2
Phase 3 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 5
Recruiting 2
Terminated 2
Unknown 2

By type:

Interventional 9
Observational 2

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 14

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy of Anti CD20 Ab Associated With Anti CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome
NCT05704400 — cells, saline solution, antibodies, pharmaceutical preparations, rituximab, nephrotic syndrome, therapeutics, nephrosis, biosimilar pharmaceuticals
Phase 2Recruiting2023

LeadR Networks

Main global connection map